# AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention

Study · id `cardio:ct-nct06235112` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06235112](<https://clinicaltrials.gov/study/NCT06235112>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06235112

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT06235112. Randomized; single masking; primary purpose prevention. Start 2024-07-31 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT06235112, source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)
- Started: 2024-07-31 (actual) (ClinicalTrials.gov record NCT06235112, source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT06235112, source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT06235112, source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06235112, source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06235112-2026-01-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
- Acronym: AI INFORM
- Condition: Coronary Artery Disease
- Intervention (Device): Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment
- Lead sponsor: Brigham and Women's Hospital
- Lead sponsor class: OTHER
- Collaborator: Nano-X Imaging Limited
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)

## Provenance

Content hash: 82f112ad153227859adf1b0386d6cf760f1e540fab1e85c3954754e33f12e512
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
